Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · November 02, 2017

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2
J. Clin. Oncol 2017 Oct 26;[EPub Ahead of Print], PA Ganz, EH Romond, RS Cecchini, P Rastogi, CE Geyer, SM Swain, JH Jeong, L Fehrenbacher, HM Gross, AM Brufsky, PJ Flynn, TA Wahl, TE Seay, JL Wade, DD Biggs, JN Atkins, J Polikoff, JL Zapas, EP Mamounas, N Wolmark

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading